PlainRecalls
FDA Drug Moderate Class II Ongoing

Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01

Reported: November 13, 2024 Initiated: October 30, 2024 #D-0039-2025

Product Description

Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01

Reason for Recall

Labeling: Missing Label

Details

Units Affected
60,594 units
Distribution
Nationwide within the USA
Location
Deerfield, IL

Frequently Asked Questions

What product was recalled?
Regadenoson Injection, 0.4 mg/5 mL (0.08 mg/mL), 5mL Single-Dose Pre-filled Syringe, Rx only, Manufactured by: Baxter Pharmaceutical Solutions, LLC, Bloomington, IN 47403; Manufactured for: Baxter Healthcare Corporation, Deerfield, IL 60015. NDC: 36000-364-01. Recalled by Baxter Healthcare Corporation. Units affected: 60,594 units.
Why was this product recalled?
Labeling: Missing Label
Which agency issued this recall?
This recall was issued by the FDA Drug on November 13, 2024. Severity: Moderate. Recall number: D-0039-2025.